Day: August 4, 2020

NEW HAVEN, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has completed the internal validation of the FDA-approved COVID-19 serology antibody test in its CLIA laboratory, and has launched the test commercially to its pathology customer base (phase 1). Upon obtaining further approval for expanded use by FDA, phase 2 will broaden our distribution to POC (point-of-care) healthcare facilities including hospitals, medical centers, urgent care facilities and physician practices.Physicians will be able to conduct a simple blood draw from each patient who wishes to be tested. The samples will be shipped overnight to Precipio’s laboratory in New Haven, where they will be received the next day, tested, and results shall be returned to the physician the same day, offering...

MONTREAL, Aug. 04, 2020 (GLOBE NEWSWIRE) — OPUS ONE Resources Inc. (the “Company” or “OPUS ONE”) – (TSX Venture Exchange: OOR), announces the first closing of a unit non-brokered private placement (the “Offering”) for total gross proceeds of $1,650,000. The first closing forms part of a larger Offering of up to 35,000,000 Units at a price of $0.05 per Unit, each unit consisting of one common share and a warrant to purchase one additional common share at a price of $0.07 for a period of three years. In total, the Company issued 33,000,000 common shares at a price of $0.05, together with accompanying share purchase warrants as described above.In connection with the first closing of Offering, the Company paid total finders’ fees of $84,800 in cash and issued 1,696,000 non-transferable share purchase warrants, each...

Draft decisions and voting form of joint stock company “GRINDEKS” Extraordinary General Meeting of shareholdersThe Management Board of joint stock company “GRINDEKS”, registration number: 40003034935, legal address: 53 Krustpils street, Riga, Latvia, LV-1057 (hereafter – the Company), considering the Covid-19 pandemic, with the aim to preserve health of shareholders, the Company’s employees as well as public in general, encourages all shareholders to participate in the Extraordinary General Meeting of shareholders to be held on August 18, 2020 in a written mode prior to the shareholders meeting by filling in voting form which is attached to this notification. We kindly ask completed voting form and send:electronically signed with the electronic signature to the Company’s e-mail address: liene.snore@grindeks.lv; orin paper form signed...

Akciju sabiedrības „GRINDEKS” ārkārtas akcionāru sapulces lēmumu projekti un balsojuma veidlapaAkciju sabiedrības „GRINDEKS”, vienotais reģ. nr. 40003034935, juridiskā adrese: Krustpils iela 53, Rīga, LV-1057 (tālāk tekstā – Sabiedrība), valde, ņemot vērā Covid-19 pandēmiju, lai aizsargātu akcionāru, Sabiedrības darbinieku un sabiedrības veselību kopumā, aicina visus akcionārus 2020. gada 18. augusta ārkārtas akcionāru sapulcē piedalīties rakstveidā, pirms akcionāru sapulces aizpildot balsojuma veidlapu, kas pievienota šī paziņojuma pielikumā. Lūdzam aizpildītu balsojuma veidlapu nosūtīt:parakstītu ar derīgu elektronisko parakstu elektroniski uz Sabiedrības e-pasta adresi: liene.snore@grindeks.lv; vaiparakstītu papīra formā uz sabiedrības pasta adresi: Krustpils iela 53 Rīga, LV-1057. Šajā gadījumā balsojuma veidlapai jābūt notariāli...

GREENVILLE, S.C., Aug. 04, 2020 (GLOBE NEWSWIRE) — Delta Apparel, Inc. (NYSE American: DLA), a leading provider of core activewear and lifestyle apparel products, today announced new retail stores for its popular Salt Life brand.  Starting in early August, Salt Life will open a series of “pop-up” stores in Florida, Georgia, and South Carolina that are in addition to two permanent stores scheduled to open this fall.On August 2, 2020, stores launched in Pooler, Georgia near Savannah, and in Woodstock, Georgia near Atlanta.  In mid-August, an additional pop-up store will open in Myrtle Beach, South Carolina. Salt Life will also add two more permanent stores in Estero and Palm Beach Gardens, Florida in September and October, respectively.Salt Life President, Jeff Stillwell, commented, “During these uncertain times, our customers have...

Draganfly invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.comLos Angeles, CA, Aug. 04, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems (“UVS”) sectors, is pleased to announce that Cameron Chell, CEO of Draganfly, will present live at VirtualInvestorConferences.com on August 6th. DATE: Thursday, August 6, 2020TIME: 2:30-3:00PM ETLINK: https://www.tinyurl.com/August6VICPRThis will be a live, interactive online event where investors are invited to ask the company questions in real-time. If...

SOMERSET, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced a new, value-added reseller relationship with Lake Health Alliance. Lake Health Alliance is a medical software sales and services organization that identifies strategic opportunities for its partners, delivering revenue cycle management (RCM), practice management, and medical billing solutions to healthcare organizations nationwide. This relationship seeks to expand the reach of MTBC’s RCM services as well as its talkEHR and CareCloud software platforms.“Lake Health Alliance is an ideal reseller and partner for MTBC,” said Karl Johnson, Division President, MTBC Force. “They will deliver MTBC’s valuable tools and personalized support services to a fresh...

Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency Laboratories Inc. Ltd (“Biocogency”). Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals Inc. upon completion of Biocogency’s transition to GAAP reporting standards and finalization of acquisition agreements.For Biocogency, this acquisition will be an opportunity to add to its already strong portfolio of biotech companies and expand its global footprint. With Rafarma, this enhanced portfolio of companies intends to expand its biotechnology business into North America, and use the synergy of the portfolio to conduct joint research projects for new health product development.Currently, Biocogency is...

JERSEY, Channel Islands, Aug. 04, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.A copy of the Company’s investor presentation will be available online on the investor relations page of the Company’s corporate website at www.quotientbd.com.About Quotient LimitedBuilding on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ...